LEP and Insulin resistance: Personalized Psychiatry and Genomic Risk Profiling: Emerging research suggests that genetic polymorphisms affecting dopamine, serotonin, and leptin pathways may predict susceptibility to antipsychotic-induced weight gain and insulin resistance.